MIP-1095 I-131

DB14978InvestigationalSmall molecule

MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).

Mechanism: Pharmacologically active on Glutamate carboxypeptidase 2
Curator reviewed
Formula / weight: C₁₉H₂₅IN₄O₈ · 568.335 g/mol (avg)
Also known as: 131I-MIP-1095
Code names: MIP-1095 I-131

Resolves to

Compound

UNII7DM27RQ9V0CAS1258980-67-4

Structure

InChIKeyLFEGKCKGGNXWDV-LUOJOMRDSA-NSMILESOC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)NC1=CC=C([131I])C=C1)C(O)=O)C(O)=O

Targets

Q04609FOLH1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with MIP-1095 I-131, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account